Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
10/28/1998 | EP0874053A2 3-Dehydroquinate synthase (aroB) |
10/28/1998 | EP0874051A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines. |
10/28/1998 | EP0874050A2 Integrin ligand ITGL-TSP |
10/28/1998 | EP0874049A1 Nucleic acid sequences of CIITA genes |
10/28/1998 | EP0873999A1 Antibody to the prorenin profragment, renin-active substance containing the same and prorenin assay reagent using the same |
10/28/1998 | EP0873755A1 Prevention and treatment of enterohemorrhagic E. coli infection |
10/28/1998 | EP0873752A2 Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine |
10/28/1998 | EP0873408A1 Calcium binding proteolipid compositions and methods |
10/28/1998 | EP0873407A1 Apo-2 ligand |
10/28/1998 | EP0873401A1 Novel retrovirus and diagnostic methods |
10/28/1998 | EP0873362A1 PROCESS FOR ISOLATING IgG AND IgA |
10/28/1998 | EP0873350A1 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3 |
10/28/1998 | EP0873140A2 Immunoconjugate for the treatment of aids |
10/28/1998 | EP0873139A1 Antibodies with reduced net positive charge |
10/28/1998 | EP0873137A1 Compositions including calcium influx blockers for inhibiting cell growth |
10/28/1998 | EP0873136A2 High fluorescence specific immune enhancing factor and methods of use for same |
10/28/1998 | EP0873135A1 Peanut allergens and methods |
10/28/1998 | EP0407392B2 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
10/28/1998 | CN1197394A Compsns. and methods for catalyzing hydrolysis of HIV gp120 |
10/28/1998 | CN1197393A Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
10/28/1998 | CN1196957A Method of extracting yolk antibody |
10/28/1998 | CN1196956A Influenza vaccine |
10/28/1998 | CN1196931A Aqueous solvent based encapsulation of bovine herpes virus type-1 subunit vaccine |
10/28/1998 | CA2231746A1 A human sodium dependent phosphate transporter (ipt-1) |
10/27/1998 | US5827935 Chimeric tRNAlys -ribozyme molecules |
10/27/1998 | US5827841 Method for enhancement of production of lymphokines and applications thereof |
10/27/1998 | US5827828 Sulfated glycolipids and antibodies thereto for prophylaxis or therapy of diabetes |
10/27/1998 | US5827817 P-selectin ligand protein |
10/27/1998 | US5827750 Human virus associated with chronic fatigue immune deficiency syndrome and assay therefore |
10/27/1998 | US5827738 Sustainable chick cell line infected with Marek's disease virus |
10/27/1998 | US5827723 Neutralizing monoclonal antibody 0.5β which binds an epitope located within the region of amino acids 308-331 of HTLVIIB gp120 |
10/27/1998 | US5827708 Nucleotide sequence which codes for the polypeptide expressed by transfer ribonucleic acid synthetase gene; screening for antibacterial compounds; from genetically enginered cells |
10/27/1998 | US5827703 Methods and composition for in vivo gene therapy |
10/27/1998 | US5827696 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
10/27/1998 | US5827692 Parasiticides against heartworm, elephantiasis |
10/27/1998 | US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology |
10/27/1998 | US5827671 Antibodies raised against proteins of Leishmania which are expressed at an increased level in the amastigote form |
10/27/1998 | US5827666 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
10/27/1998 | US5827647 Treating samples with isolated empty parvovirus capsids, then detecting antigen-antibody complexes for diagnosis, also kits |
10/27/1998 | US5827519 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
10/27/1998 | US5827517 CCK antibodies used to improve feed efficiency |
10/27/1998 | US5827516 Decreasing major histocompatibility complex class ii antigen in mammal by introducing into antigen presenting cell an expression vector comprising a nucleic acid molecule coding for expression of peptide which binds to mhc class ii molecule |
10/27/1998 | CA2078694C Hepatitis b vaccine |
10/27/1998 | CA2063721C Mycobacterium chelonae polar glycopeptidolipids-based immune booster medication |
10/27/1998 | CA1340103C Cloning of dna for protozoal antigens |
10/24/1998 | CA2228743A1 Novel integrin ligand itgl-tsp |
10/23/1998 | CA2235457A1 Prevention and treatment of enterohemorrhagic e. coli infection |
10/23/1998 | CA2229430A1 Aqueous solvent based encapsulation of bovine herpes virus type-1 subunit vaccine |
10/22/1998 | WO1998046785A1 Dendritic cell hybrids |
10/22/1998 | WO1998046769A1 Composition and method for inducing an immune response against tumour-related antigens |
10/22/1998 | WO1998046761A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
10/22/1998 | WO1998046758A1 Human tumor-associated kazal inhibitor |
10/22/1998 | WO1998046751A1 Osteoprotegerin binding proteins and receptors |
10/22/1998 | WO1998046746A1 Extracellular/epidermal growth factor like protein |
10/22/1998 | WO1998046743A1 Novel ldl-receptor |
10/22/1998 | WO1998046742A2 Dictyocaulus viviparus antigen for the diagnosis of lungworm disease and for vaccination |
10/22/1998 | WO1998046725A2 Attenuated, invasive vaccines against fish pathogens |
10/22/1998 | WO1998046645A2 Method for the production of antihuman antigen receptors and uses thereof |
10/22/1998 | WO1998046644A1 Novel protein and process for producing the same |
10/22/1998 | WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA |
10/22/1998 | WO1998046640A2 Methods and compositions for inducing immunosuppression |
10/22/1998 | WO1998046638A1 A novel th2-specific gene |
10/22/1998 | WO1998046264A1 Antagonistic anti-avb3 integrin antibodies |
10/22/1998 | WO1998046263A1 Saponin adjuvants in combination with dna vaccination |
10/22/1998 | WO1998046262A1 Anti-influenza compositions supplemented with neuraminidase |
10/22/1998 | WO1998046261A1 Vaginal lactobacillus medicant |
10/22/1998 | WO1998046260A1 Pasteurella haemolytica vaccine |
10/22/1998 | WO1998046259A1 Non-antibiotic system for selection of recombinant mycobacteria |
10/22/1998 | WO1998046246A1 α-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF |
10/22/1998 | WO1998046243A2 Pharmaceutical compositions having appetite suppressant activity |
10/22/1998 | WO1998046242A1 Treatment of cancer by the administration of fas ligand expressing non-tumorigenic cells |
10/22/1998 | WO1998046209A1 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
10/22/1998 | WO1998036068A3 Human p24 vesicle proteins |
10/22/1998 | WO1998030685A3 Purification and/or concentration of dna by cross-flow filtration, separation of endotoxins from a nucleic acid preparation |
10/22/1998 | DE19715586A1 Dictyocaulus viviparus Antigen zur Diagnose des Lungenwurmbefalls und zur Vakzinierung Dictyocaulus viviparus antigen for the diagnosis of lung worm infestation and for vaccination |
10/22/1998 | CA2781623A1 Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same |
10/22/1998 | CA2706609A1 Osteoprotegerin binding proteins and receptors |
10/22/1998 | CA2584411A1 Pharmaceutical compositions having appetite suppressant activity |
10/22/1998 | CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna |
10/22/1998 | CA2287779A1 Human tumor-associated kazal inhibitor |
10/22/1998 | CA2287518A1 A novel th2-specific gene |
10/22/1998 | CA2286798A1 Alpha-o-linked glycoconjugates with clustered(2,6)-st epitopes, methods of preparation and uses thereof |
10/22/1998 | CA2286477A1 Composition and method for inducing an immune response against tumour-related antigens |
10/22/1998 | CA2286351A1 Extracellular/epidermal growth factor like protein |
10/22/1998 | CA2284726A1 Antagonistic anti-avb3 integrin antibodies |
10/22/1998 | CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor |
10/22/1998 | CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor |
10/22/1998 | CA2229428A1 3-dehydroquinate synthase (arob) |
10/21/1998 | EP0872553A1 Chimeric and/or growth-restricted flaviviruses |
10/21/1998 | EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor |
10/21/1998 | EP0872486A1 Eimeria proteins as vaccines |
10/21/1998 | EP0872249A1 Gene transfer preparation |
10/21/1998 | EP0871883A1 Compounds and methods related to parathyroid hormone-like protein |
10/21/1998 | EP0871755A1 Vectors for gene delivery |
10/21/1998 | EP0871748A2 Delivery of biologically active polypeptides |
10/21/1998 | EP0871747A1 Immunostimulation mediated by gene-modified dendritic cells |
10/21/1998 | EP0871738A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
10/21/1998 | EP0871735A1 Therapeutic and diagnostic compositions |
10/21/1998 | EP0871734A1 Polypeptide fragments capable of competition with streptococcus mutans antigen i/ii |
10/21/1998 | EP0871733A2 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |